These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1839081)

  • 1. Growth factors in the regulation of plasminogen-plasmin system in tumor cells.
    Keski-Oja J; Koli K; Lohi J; Laiho M
    Semin Thromb Hemost; 1991 Jul; 17(3):231-9. PubMed ID: 1839081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasminogen activator inhibitor system in bone cell function.
    Allan EH; Martin TJ
    Clin Orthop Relat Res; 1995 Apr; (313):54-63. PubMed ID: 7641498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proteolysis directed by the extracellular matrix].
    Hornebeck W; Emonard H; Maquart FX; Bellon G
    J Soc Biol; 2003; 197(1):25-30. PubMed ID: 12868263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor secretion of growth factors.
    Daughaday WH; Deuel TF
    Endocrinol Metab Clin North Am; 1991 Sep; 20(3):539-63. PubMed ID: 1718747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine and paracrine regulation of tissue inhibitor of metalloproteinases, transin, and urokinase gene expression in metastatic and nonmetastatic mammary carcinoma cells.
    Korczak B; Kerbel RS; Dennis JW
    Cell Growth Differ; 1991 Jul; 2(7):335-41. PubMed ID: 1782152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor beta that can be activated by neural crest cell proteolysis.
    Brauer PR; Yee JA
    Dev Biol; 1993 Jan; 155(1):281-5. PubMed ID: 8416842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC; Quax PH; Löwik CW; Verheijen JH
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.
    Yee JA; Yan L; Dominguez JC; Allan EH; Martin TJ
    J Cell Physiol; 1993 Dec; 157(3):528-34. PubMed ID: 8253864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin in pericellular proteolysis and cellular invasion.
    Kramer MD; Reinartz J; Brunner G; Schirrmacher V
    Invasion Metastasis; 1994-1995; 14(1-6):210-22. PubMed ID: 7657514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
    Lázár-Molnár E; Hegyesi H; Tóth S; Falus A
    Cytokine; 2000 Jun; 12(6):547-54. PubMed ID: 10843728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases.
    Angelloz-Nicoud P; Harel L; Binoux M
    Growth Regul; 1996 Sep; 6(3):130-6. PubMed ID: 8894645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
    Fibbi G; Pucci M; Grappone C; Pellegrini G; Salzano R; Casini A; Milani S; Del Rosso M
    Hepatology; 1999 Mar; 29(3):868-78. PubMed ID: 10051491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pericellular enzymatic hydrolysis: implications for the regulation of cell proliferation in the vessel wall and the bone marrow.
    Brunner G; Preissner KT
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):625-39. PubMed ID: 7841321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
    Bechtel MJ; Reinartz J; Rox JM; Inndorf S; Schaefer BM; Kramer MD
    Exp Cell Res; 1996 Mar; 223(2):395-404. PubMed ID: 8601416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator expression and matrix degradation.
    Rifkin DB
    Matrix Suppl; 1992; 1():20-2. PubMed ID: 1480022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and activation of plasminogen on the surface of osteosarcoma cells.
    Campbell PG; Wines K; Yanosick TB; Novak JF
    J Cell Physiol; 1994 Apr; 159(1):1-10. PubMed ID: 7511144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
    Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
    Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.